Invention Grant
- Patent Title: Methods for reprogramming cells and uses thereof
-
Application No.: US15298034Application Date: 2016-10-19
-
Publication No.: US10260046B2Publication Date: 2019-04-16
- Inventor: Jan-Eric Ahlfors , Rouwayda El-Ayoubi
- Applicant: GENESIS TECHNOLOGIES LIMITED
- Applicant Address: BB Warrens, St. Michael
- Assignee: Genesis Technologies Limited
- Current Assignee: Genesis Technologies Limited
- Current Assignee Address: BB Warrens, St. Michael
- Agency: Knobbe, Martens, Olson & Bear LLP
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/0775 ; C12N5/0797 ; C12N5/079 ; C12N5/074 ; A61K35/30 ; C12N5/0789 ; C12N5/077 ; C12N5/0793 ; C12N5/071 ; A61K35/545

Abstract:
A method of obtaining a cardiac multipotent or unipotent cell, comprising: i) providing a cell of a first type which is not a cardiac multipotent or unipotent cell; ii) introducing into the cell of a first type an agent capable of remodeling the chromatin and/or DNA of the cell, wherein the agent capable of remodeling the chromatin and/or DNA is a histone acetylator, an inhibitor of histone deacetylation, a DNA demethylator, and/or a chemical inhibitor of DNA methylation; iii) introducing into the cell of a first type a reprogramming polypeptide and/or a polynucleotide encoding said reprogramming polypeptide, wherein the reprogramming polypeptide comprises Mesp1, Brachyury (T), Nkx2.5, and/or Tbx5; and iv) placing or maintaining the cell in a cardiac cell culture medium and maintaining intracellular levels of the reprogramming polypeptide or the polynucleotide encoding the reprogramming polypeptide for a sufficient period of time to allow a cardiac multipotent or unipotent cell to be obtained.
Public/Granted literature
- US20170101626A1 METHODS FOR REPROGRAMMING CELLS AND USES THEREOF Public/Granted day:2017-04-13
Information query